We are allied with production and R/D facilities on a product exclusivity basis to develop and conduct separate trials in a sustainable yet cost-effective manner for our customers.

We are engaged in the supply KSM’s (Key Starting Materials) APIs and Excipients.

The manufacturing facilities are approved by PIC/s, INVIMA, COFEPRIS and WHO-GMP while ANVISA is in pipeline such accreditations enable us to explore our offerings to semi-regulated and regulated markets.